MedTrace Logo

Fecal Calprotectin Levels in Patients With Fibromyalgia

NCT05404893 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2023-01-18

No results posted yet for this study

Summary

This study was designed to evaluate fecal calprotectin levels in patients with fibromyalgia syndrome. Fecal calprotectin levels from fibromyalgia patients with and without gastrointestinal symptoms as well as healthy controls will be measured and compared.

Conditions

Interventions

DIAGNOSTIC_TEST

Fecal calprotectin measurement

Stool samples will be collected and fecal calprotectin levels will be measured using an enzymatic immunoassay kit.

Sponsors & Collaborators

  • Ege University

    lead OTHER

Principal Investigators

  • Ece Cinar, MD · Ege university school of medicine

  • Burcu Turkoglu Aytar, MD · Kirsehir Ahievran University School of Medicine

  • Simin Hepguler, Prof. · Ege university school of medicine

  • Burcu Barutcuoglu, Ass.Prof. · Ege university school of medicine

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-04-01
Primary Completion
2022-06-07
Completion
2022-09-30

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05404893 on ClinicalTrials.gov